The Crossfit Stack pairs LGD-4033 with GW-1516 to support advanced research into strength and metabolic signaling pathways. Preclinical research has explored LGD-4033 for its selective androgen receptor interaction in muscle and bone tissue models.

GW-1516 has been investigated for its activation of PPAR-delta receptors and its role in lipid metabolism and endurance-related signaling in experimental environments. Together, these compounds allow researchers to examine complementary receptor systems.

Each compound is independently tested for identity and purity before release. This stack is intended strictly for laboratory research and is not for human consumption.